UUIDt6'FFIC39-8A92-44AF-BF52-341368174119

 

 

TceA-LN-A4As-a1A-pn Redacted
||| Illlllllllllllll ||||||||||IIllllIIlllllllllllllIllllllllllllllll
||| "mm“I"I“IIII"llI"lllllilllliillillllillﬂlllliII”“Hum" Q
IllIIIHII||||||||||||||||||||l T3,: Fax; \ --
Clinical Case Report
I Cb ’0 ’5 (For Collection of Cancerous Tlssue)

CWW, SW all, M?! 90 70/3
3 (7‘15 (.4an mww Cl—“V
MM,»

Informed Consen-

I personally informed this patient that a specimen(s) would be collected to be used for research
purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT
FORM with the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this informed consent document will be retained at
our institution; ’

Name of Physician or Study Coordinator signature Date

 

, [glinical Informatioﬁ
GENERAL I N

A

D Single jZMarried ' -

Gender El Divorced El Widow Blood Pressure Heart Rate
Male El Female

 

 

 

”HISTORY OEPRESENT'ILLNESS. ‘ . ’ - ' -

ChiefComplaints:V%-¢L(O.& ,gunﬂﬁalxn‘ma 2' decaf MW

 

Symptom“ 73'er 0i ‘Q‘IUW

 

Clinical Flndings:

 

Performance Scale (Kamofsky Score):
a 100 Asymptomatic n 80~90 Symptomatic but Fully Ambulatory )i'GO-70 Symptomatic, in bed less than 50% of day
‘ a 40-50 Symptomatic, in bed more than 50% of day: but not bed ridden a 20-30 Bed Ridden

 

 

 

MED CATIONS ~

 

PAST MEDICAL HISTORY

 

 

 

 

 

 

 

 

 

‘ ’ OB/GYNHISTORY' v- -‘- ., ‘ '
Menopausal Status Date of Flrst Mensee # of Pregnancies
El Pro-menopausal
El Peri-Menopausal Date of Last Menses # of LIVE Births
D Post-menopausal
Birth Control: a Condom u Oral Contraceptive a IUD D Hormone Replacement
D Other: 1 Therapy:

 

 

 

Duration

Alcohol Consum

Use

Duration

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

' A v , ' LAB DATA . ‘
Test Result T Date I Test Result Data
HIV vEtiegative Cl Positive:__ CEA El Negative Cl Positive:

Hep B leNegative El Positive: ' CA 15-3 El Negative D Positive:

Hep C )2! Negative :3 Positive: CA 19-9 L'J motive El Positive:
AF P Cl Negative D Positive: PSA [:1 Negative :1 Positive:

Other: Cl Negative [21 Positive: Other: [:1 Negative El Positive:

B/T Cell Markers:

 

 

i DIAGNOSTIC STUDIES " '

Ultrasound
x-
CT

M 0 stage: 32:

ﬂeatment Information]

 

 

Date of Procedure

Palpable, Non-Dissected Lymph Nodes
Dissected Lymph Nodes

Distant Metastasis

 

Pathology Form

 

Specimen Informatioﬁ

Collected by: __ __ Date. ‘ime
Preserved by: _ __ Date fime

#of'

Diseased Normal Diseased Diseased Normal

Time to LN2 Time to Formalin Time to LNZ
' min

PATHOLOGICAL D

Prlma Tumor
Size ofTumor Distanceto NAT

x cm " ‘ ‘ cm

Nodes
#

Distant Metastasis

Notes:

 

CONSOLIDATED DIAGNOSTIC PATHOLOGY FORM*

Microscopic Appearance:

1.

DISTRIBUTION

Ditfnse
Mosaic
Necrosis
L
Vascular Invasion
Clusterized "
Alveolar Formation
Indian File . PsammomalCalciﬁcation

2.

+ - Sarcomatons + -
cell . Round Cell Cell
Cell Cell Stratiﬁcation Small

Kerstin Secretion RS Like
Desmosome V Inﬂam. Cell

formation Plasma Cell
Otherwise

 

2. Cellular Di emulation:
Well Moderately Poor

 

 

 

 

 

 

 

3. Nuclear A

Nuclear
Anise Nucleosis

Prominent
Giant

Nuclear Grade

 

Histological Diagnosis: 8 ' 6‘12.

Comments:

 

V —— Date
Director, Research Pathology

*(INTEGRATED REPORT OF FINDINGS BY CONTRIBUTOR AND ’ATHOLOGIST STAFF FOR RESEARCH USE ONLY).

  

